Yu‐Hung Chang

983 total citations
27 papers, 787 citations indexed

About

Yu‐Hung Chang is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Yu‐Hung Chang has authored 27 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 8 papers in Epidemiology. Recurrent topics in Yu‐Hung Chang's work include Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Lipoproteins and Cardiovascular Health (4 papers). Yu‐Hung Chang is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Lipoproteins and Cardiovascular Health (4 papers). Yu‐Hung Chang collaborates with scholars based in Taiwan, United States and China. Yu‐Hung Chang's co-authors include Yau‐Jiunn Lee, Shyi‐Jang Shin, Dao‐Ming Chang, Kun‐Der Lin, Chang‐Hsun Hsieh, Kun‐Chen Lin, Chung‐Yu Chang, Tsong-Ming Lee, Pi‐Jung Hsiao and De-Kuan Chang and has published in prestigious journals such as Metabolism, Diabetes Obesity and Metabolism and European Journal of Neurology.

In The Last Decade

Yu‐Hung Chang

27 papers receiving 764 citations

Peers

Countries citing papers authored by Yu‐Hung Chang

Since Specialization

Citations

This map shows the geographic impact of Yu‐Hung Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Hung Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Hung Chang more than expected).

Fields of papers citing papers by Yu‐Hung Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Hung Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Hung Chang. The network helps show where Yu‐Hung Chang may publish in the future.

Co-authorship network of co-authors of Yu‐Hung Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Hung Chang. A scholar is included among the top collaborators of Yu‐Hung Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Hung Chang. Yu‐Hung Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inter-relationship of risk factors and pathways associated with chronic kidney disease in patients with type 2 diabetes mellitus: a structural equation modelling analysis 2021 ·Public Health ·(unknown), Yung‐Chuan Lu, Wei‐Chin Hung, I‐Ting Tsai, Yu‐Hung Chang, (unknown), Chia‐Chang Hsu, (unknown), (unknown), Fu‐Mei Chung, Yau‐Jiunn Lee	11
2	<p>Common and Unique Factors and the Bidirectional Relationship Between Chronic Kidney Disease and Nonalcoholic Fatty Liver in Type 2 Diabetes Patients</p> 2020 ·Diabetes Metabolic Syndrome and Obesity ·Yau‐Jiunn Lee, Chao-Ping Wang, Wei‐Chin Hung, Weihua Tang, Yu‐Hung Chang, (unknown), Yung‐Chuan Lu, Teng‐Hung Yu, Cheng‐Ching Wu, Fu‐Mei Chung, Chia‐Chang Hsu	13
3	Pioglitazone and statins lower incidence of Parkinson disease in patients with diabetes mellitus 2020 ·European Journal of Neurology ·Yu‐Hung Chang, (unknown), (unknown), Wenjuan Wu, Kun‐Der Lin	30
4	Renal function preservation with pioglitazone or with basal insulin as an add-on therapy for patients with type 2 diabetes mellitus 2017 ·Acta Diabetologica ·Yu‐Hung Chang, (unknown), Dao‐Ming Chang, (unknown), Chang‐Hsun Hsieh, Yau‐Jiunn Lee	10
5	Benefits of Rosuvastatin in Cardiovascular Protection Remain Unclear After HOPE-3 2016 ·The Review of Diabetic Studies ·Yu‐Hung Chang, (unknown), (unknown), (unknown)	3
6	Changes in high-density-lipoprotein cholesterol upon statin treatment in type 2 diabetic patients: A meta-analysis 2014 ·Nutrition Metabolism and Cardiovascular Diseases ·Yu‐Hung Chang, Kun‐Der Lin, Shyi‐Jang Shin, (unknown)	2
7	Paradoxical Negative HDL Cholesterol Response to Atorvastatin and Simvastatin Treatment in Chinese Type 2 Diabetic Patients 2013 ·The Review of Diabetic Studies ·Yu‐Hung Chang, (unknown), Dao‐Ming Chang, (unknown), (unknown)	7
8	Developing and Psychometric Testing of a Short-Form Problem Areas in Diabetes Scale in Chinese Patients 2013 ·Journal of Nursing Research ·Hui‐Chun Hsu, Yu‐Hung Chang, Pei-Ju Lee, Shi‐Yu Chen, Chang‐Hsun Hsieh, Yau‐Jiunn Lee, Ruey‐Hsia Wang	21
9	Reassessing the Benefits of Statins in the Prevention of Cardiovascular Disease in Diabetic Patients - A Systematic Review and Meta-Analysis 2013 ·The Review of Diabetic Studies ·Yu‐Hung Chang, (unknown), (unknown), (unknown), (unknown)	14
10	High-density lipoprotein cholesterol and the risk of nephropathy in type 2 diabetic patients 2012 ·Nutrition Metabolism and Cardiovascular Diseases ·Yu‐Hung Chang, De-Kuan Chang, (unknown), Chang‐Hsun Hsieh, (unknown)	45
11	One-Year Efficacy and Safety of the Telehealth System in Poorly Controlled Type 2 Diabetic Patients Receiving Insulin Therapy 2011 ·Telemedicine Journal and e-Health ·Shi‐Yu Chen, Yu‐Hung Chang, Hui‐Chun Hsu, Yau‐Jiunn Lee, Yi‐Jen Hung, Chang‐Hsun Hsieh	17
12	Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy 2011 ·Metabolism ·Yu‐Hung Chang, Kun‐Der Lin, (unknown), Ming‐Chia Hsieh, Jeng‐Yueh Hsiao, Shyi‐Jang Shin	39
13	Albuminuria Is the Stronger Risk Factor for Peripheral Arterial Disease than eGFR Decline in a Type 2 Diabetic Taiwanese Population 2010 ·Kidney & Blood Pressure Research ·(unknown), Kun‐Der Lin, Yu‐Hung Chang, Pi‐Jung Hsiao, Shyi‐Jang Shin	9
14	Fulminant Type 1 Diabetes Mellitus Leading to Fetal Loss in a Pregnant Chinese Woman 2010 ·The Kaohsiung Journal of Medical Sciences ·(unknown), Kun‐Der Lin, Yu‐Hung Chang, Ming‐Chia Hsieh, Pi‐Jung Hsiao, Shyi‐Jang Shin	3
15	Diabetic Muscle Infarction in Association with Terlipressin Therapy: A Case Report 2009 ·The Kaohsiung Journal of Medical Sciences ·Yu‐Hung Chang, (unknown), Ming‐Chia Hsieh, Kun‐Der Lin, Shyi‐Jang Shin, (unknown)	3
16	High-sensitivity C-reactive protein and silent myocardial ischemia in Chinese with type 2 diabetes mellitus 2008 ·Metabolism ·Ming‐Chia Hsieh, Kai‐Jen Tien, Shun‐Jen Chang, Daw‐Shyong Perng, Jeng‐Yueh Hsiao, Yu‐Wen Chen, Yu‐Hung Chang, (unknown), (unknown)	13
17	Elevated serum retinol‐binding protein 4 concentrations are associated with renal dysfunction and uric acid in type 2 diabetic patients 2008 ·Diabetes/Metabolism Research and Reviews ·Yu‐Hung Chang, Kun‐Der Lin, (unknown), Ming‐Chia Hsieh, Pi‐Jung Hsiao, Shyi‐Jang Shin	22
18	Thiazolidinedione addition reduces the serum retinol-binding protein 4 in type 2 diabetic patients treated with metformin and sulfonylurea 2008 ·Translational research ·Kun‐Der Lin, Yu‐Hung Chang, (unknown), Yi‐Hsin Yang, Pi‐Jung Hsiao, (unknown), Shyi‐Jang Shin	21
19	Insulinoma‐associated Transient Hypothalamus—Pituitary—Adrenal Axis Impairment and Amelioration by Steroid Therapy and Surgical Intervention: A Case Report 2007 ·The Kaohsiung Journal of Medical Sciences ·Yu‐Hung Chang, Ming‐Chia Hsieh, (unknown), Shyi‐Jang Shin, Kun‐Der Lin	5
20	Characterisation of drug resistance gene cassettes associated with class 1 integrons in clinical isolates of Escherichia coli from Taiwan, ROC 2000 ·Journal of Medical Microbiology ·Chung‐Yu Chang, Yu‐Hung Chang, (unknown), (unknown), Tsong-Ming Lee	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact